The first and only
prescription app for MDD
symptoms1
When your adult patients age 22+ want to add to their current ADT, consider Rejoyn, a novel
treatment for MDD symptoms.1
Complements your care
Rejoyn is a prescription digital therapeutic that works alongside their ADT.2
6-week treatment
Rejoyn is 6 weeks of cognitive-emotional training (CET) exercises and cognitive behavioral therapy (CBT)-based video lessons that patients complete on their smartphone and on their own time.2
Reduced MDD symptoms
In a clinical trial, adding Rejoyn to ADT reduced MDD symptoms with zero adverse events related to Rejoyn.2
Designed to target dysregulated neural networks
in the brain2
Dysregulation has been associated with MDD2
Imaging of patients with depression has shown hyperactivity in emotion centers, like the amygdala, and hypoactivity in cognitive areas, like the prefrontal cortex.2
Dysregulated connectivity between the prefrontal cortex and the amygdala can cause patients to experience impaired cognitive control of emotion.2
Tapping into neuroplastic potential may reduce MDD symptoms2
The CET brain exercises in Rejoyn are designed to simultaneously activate the amygdala and prefrontal cortex. Repeated coordination of both regions over 6 weeks may strengthen their connection. This is thought to help enhance cognitive control of emotion, which may help reduce depression symptoms.2
Dysregulation has been associated with MDD2
Imaging of patients with depression has shown hyperactivity in emotion centers, like the amygdala, and hypoactivity in cognitive areas, like the prefrontal cortex.2
Dysregulated connectivity between the prefrontal cortex and the amygdala can cause patients to experience impaired cognitive control of emotion.2